Newsletter Subject

5 Dead and Over 100 Hospitalized From Recalled Japanese Health Supplements

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Sat, Apr 6, 2024 11:15 AM

Email Preheader Text

Weekly Review Saturday, April 06, 2024 THE BREAK ROOM CME SPOTLIGHT THE BREAK ROOM ADVERTISEMENT CME

[MEDPAGE TODAY]( Weekly Review Saturday, April 06, 2024 [5 Dead and Over 100 Hospitalized From Recalled Japanese Health Supplements]( [How Old Is Too Old for Surveillance Colonoscopy?]( [Smartphone Tests Detect Frontotemporal Dementia]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Optimizing Treatment With Infusion-Based Therapies for HR+/HER2- and Triple-Negative Breast Cancer]( [The Baltimore Bridge Collapse Aftermath: Determining Causes of Death]( [Aspirin for Fatty Liver; Meds for Self-Managed Abortion]( THE BREAK ROOM [Play Today's Wordosis: Our Medical Word Game]( ADVERTISEMENT [Weight-Loss Drug Zepbound Faces Supply Issues]( CME SPOTLIGHT [Improving Real-World Care For Veteran Patients With Hepatocellular Carcinoma: Strategies for Patient-Centered, Teams-Based Approaches]( [Caffeine and Parkinson's; Brutally Honest Look at Dementia; Three MS Subtypes]( [Forget 'Pack-Years' for Lung Cancer Screening Eligibility, Study Suggests]( [More Women Are Drinking Themselves Sick. The Biden Administration Is Concerned.]( CME SPOTLIGHT [Expert Insights and System-Based Care Trends in Early-Stage NSCLC and Melanoma, Metastatic Bladder Cancer, and Relapsed/Refractory Follicular Lymphoma]( [Chatbot Beat Doctors on Clinical Reasoning]( [Diabetes Drug Shows Benefit in Parkinson's Disease]( [Paxlovid Fails to Shorten COVID in Standard-Risk and Vaccinated At-Risk Patients]( CME SPOTLIGHT [Latest Clinical Evidence in Adult Diffuse Low-Grade Glioma]( [Flu Vaccine Uptake Tripled With Simple Promotion]( [New Allegations in Doc's Drano Poisoning Case; $535M Behavioral Health Verdict]( [FDA Approves TriClip; Fortified Eggs vs Cholesterol; Impella Maker Chided]( CME SPOTLIGHT [Applying the Latest Clinical Evidence to Treatment Plans for Pediatric Patients With Hodgkin Lymphoma]( [Here's What OTC Continuous Glucose Monitors Can Do for Our Patients]( [Despite Pushback, Anti-DEI Congressman to Speak at Medical Meeting]( [Court Rules Against Pharmacist Who Refused Emergency Contraception Prescription]( CME SPOTLIGHT [Employing Collaborative Care Strategies for the Management of Pediatric Patients With Hodgkin Lymphoma]( [E-Cigarettes Tied to Heart Failure]( [How to Safely Watch a Solar Eclipse]( [When Medicalization Goes Too Far]( CME SPOTLIGHT [Leveraging the Multidisciplinary Team to Improve Lung Cancer Care]( [GLP-1 Users May Have Increased Endoscopy-Related Aspiration Pneumonia Risk]( [ACC Meeting to Make Noise on Beta-Blockers, SGLT2i, Chelation Therapy for Acute MI]( [A Tornado Ripping Through the Body: Streptococcal Toxic Shock Syndrome]( CME SPOTLIGHT [PARP Prodigy: Mastering Metastatic Castration-Resistant Prostate Cancer]( [Cancer 'Tidal Wave' Forecast; Not Decaf, Too! Cautionary Tales of Cancer, Cannabis]( ['Numerous Studies Prove Them Wrong': What We Heard This Week]( [Condemned Inmate Could Face 'Surgery Without Anesthesia,' Lawyers Say]( [PSA and Biomarker Testing Plus MRI Appears to Improve Prostate Cancer Screening]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2024 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_DHE_Weekly?xid=nl_mpt_DHE_2024-04-06&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.